Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – Contrary to persistent concerns, the use of tumor necrosis factor (TNF)-alpha antagonists, as a group, to treat autoimmune diseases is not associated with…
NEW YORK (Reuters Health) – For stable patients with left main coronary artery disease, percutaneous coronary intervention (PCI) is a “reasonable” alternative to coronary artery bypass grafting (CABG)…
NEW YORK (Reuters Health) – Toremifene significantly decreases new vertebral fractures in younger men receiving androgen deprivation therapy (ADT) for prostate cancer, researchers report in an October 19th…
NEW YORK (Reuters Health) – Vandetanib shows encouraging action against advanced and metastatic medullary thyroid carcinoma, researchers report in an October 24th on-line paper in the Journal of…
NEW YORK (Reuters Health) – Energy-based vessel sealing appears to decrease operating time, blood loss, and hospital stay in women undergoing vaginal hysterectomy, researchers say. “Energy-based vessel sealing…
NEW YORK (Reuters Health) – Women who deliver their first baby with a cesarean section face an increased risk of adverse reproductive outcomes in subsequent pregnancies, according to…
NEW YORK (Reuters Health) – In patients with chronic coronary artery disease, prasugrel overcomes high on-clopidogrel platelet reactivity more effectively than doubling the dose of clopidogrel, results of…
NEW YORK (Reuters Health) – More intensive blood glucose lowering won’t reduce the risk of heart failure in patients with type 2 diabetes, and when achieved with a…
NEW YORK (Reuters Health) – Thoracoscopic unilateral extended thymectomy (TUET) is “the best treatment option” for patients undergoing surgery for nonthymomatous myasthenia gravis, clinicians from Romania conclude in…
NEW YORK (Reuters Health) – Hospitalized nonsurgical patients (medical patients and those with acute stroke) should receive pharmacologic venous thromboembolism (VTE) prophylaxis, unless the risk for bleeding outweighs…
